Corient Private Wealth’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Corient Private Wealth's CL Position: Q2 2026 in Review
Corient Private Wealth increased its Colgate-Palmolive (CL) stake by 39% in Q2 2026, buying an estimated $16.7M and bringing the position to 686,792 shares worth $63M. The position accounts for 0.08% of the portfolio, ranked #215.
Corient Private Wealth first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $85.1M in Q4 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Corient Private Wealth held 686,792 shares of Colgate-Palmolive worth $63M as of Q2 2026.
- Corient Private Wealth bought 191,000 Colgate-Palmolive shares in Q2 2026, an estimated $16.7M.
- Colgate-Palmolive made up 0.08% of Corient Private Wealth's portfolio in Q2 2026, its #215 holding.
- Corient Private Wealth first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
- Corient Private Wealth's Colgate-Palmolive position peaked at $85.1M in Q4 2025.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.